BridgeBio Pharma, Inc. (BBIO)
72.28
-0.87
(-1.19%)
USD |
NASDAQ |
Apr 06, 16:00
72.31
+0.03
(+0.04%)
After-Hours: 20:00
BridgeBio Pharma Market Cap : 13.85B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 155.85B |
| Insmed, Inc. | 35.61B |
| Mirum Pharmaceuticals, Inc. | 5.935B |
| Supernus Pharmaceuticals, Inc. | 2.917B |
| Apellis Pharmaceuticals, Inc. | 5.222B |
Market Cap Related Metrics
| PS Ratio | 27.25 |
| PEG Ratio | -0.5739 |
| Price | 72.28 |
| Earnings Yield | -5.30% |
| PEGY Ratio | -0.5739 |